🇺🇸 FDA

Company profile · Sponsor

Suzhou

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

CE53A01 · NMPA biotech CN
Pipeline
3
Drugs
0
Patents
0

Quick answer

Suzhou (CE53A01) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CE53A01
Exchange NMPA
Company type biotech
Headquarters CN

Pipeline (3)

Search pipeline →

  1. Alkotinib Capsules

    Suzhou

    ALK-positive Non-small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  2. ZG005

    Suzhou

    Biliary Tract Carcinoma

    phase 2 small molecule active

    1 trial

  3. ZG0895 Hydrochloride for Injection

    Suzhou

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Suzhou?

Suzhou (CE53A01) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Suzhou sponsor?

We track 3 ClinicalTrials.gov-linked programs for Suzhou, including Alkotinib Capsules and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Suzhou company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.